source
- ADA ‘26: Lilly’s dominance, Pfizer’s ‘foundational’ drug and Roche’s ‘me-too’ optionAt a big meeting for weight loss drugs, Lilly’s “triple G” therapy set a new standard as lingering doubts surrounded other competing treatments.BioPharma Dive · 2mo ago↗ source
- STAT+: UnitedHealthcare’s lactation billing feud, and fake strokesThe biggest U.S. health insurer is changing how it pays for lactation counseling, and it could cut payment for many providers.STAT · 2mo ago↗ source
- J&J makes $1B move for Firefly Bio, Carolyn Bertozzi's twist on ADCs in KRAS fieldJohnson & Johnson is making another early-stage oncology deal, dishing out $1 billion in cash to acquire Firefly Bio, a preclinical startup working on degrader antibody conjugates. J&J now joins th…